Enterome
@enterome.com
We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
Enterome's Company Logos
Enterome's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#FFDD57
Mustard
255, 221, 87
48, 100, 67
0, 13, 66, 0
#D5A150
Di Serria
213, 161, 80
37, 61, 57
0, 24, 62, 16
#B3202A
Mexican Red
179, 32, 42
356, 70, 41
0, 82, 77, 30
About Enterome
Enterome is a clinical-stage biopharmaceutical company that specializes in developing breakthrough immunomodulatory drugs for the treatment of cancer. Their primary focus is on their OncoMimics™ peptides, which are designed to modulate the immune system and target specific antigens, hormones, or cytokines. What sets Enterome apart is their unique approach to drug discovery, which is centered around understanding the intricate interactions between the gut microbiome and the immune system.
By leveraging their Mimicry drug discovery platform, they are able to analyze a vast database of over 20 million full-length gut microbiome proteins to identify novel therapeutic candidates. Currently, Enterome is advancing their proprietary OncoMimics™ pipeline, which includes distinct drug candidates for glioblastoma, adrenal tumors, indolent non-Hodgkin lymphomas, and colorectal cancer. With a highly experienced leadership team and a commitment to innovation, Enterome is at the forefront of developing transformative drugs that have the potential to revolutionize cancer treatment
Company type
Privately Held
Year founded
2011
Company size
51-200 employees
